ALS patients can’t afford the wait. Fast track decision on bring drug to the United States
0 have signed. Let’s get to 35,000!
It’s been over 20 years since a new treatment for ALS, a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord, has been available in the US. That could all change with Radicava, a drug already available in other countries and that extends the lives of those with ALS.
The Food and Drug Administration (FDA) is reviewing the drug and say it should make a decision by summer of 2017 -- that is too long. And even if a decision to bring the drug to market is reached, it could take 6 months to get it to pharmacies.
People suffering from ALS need this drug, thousands of patients will not make it that long and need access as soon as possible. This isn’t the case of a drug that has never been available to the public and where higher scrutiny would be understandable. Radicava has been available in Japan and South Korea, and hasn’t shown anything that would indicate it is not safe.
Sign our petition telling the FDA to expedite their decision. People with ALS should not have to wait for a proven drug until the end of 2017, or possibly not until 2018. It’s been 20 years since any kind of new treatment for this awful disease -- they’ve waited long enough.
Today: Dan is counting on you
Dan Kelleher needs your help with “Federal Drug Administration: ALS patients can’t afford the wait -- fast track decision on bring drug to the United States”. Join Dan and 26,820 supporters today.